News Hub | News Direct

Cold and Flu Season 2022: How Over-the-Counter Remedies Can Help

YourUpdateTV

Flu season has almost always been a predictable part of every winter, but the COVID-19 pandemic threw things out of whack. The 2020-2021 flu season was practically non-existent due to COVID-19 precautions and lockdowns, and last year’s flu season was definitely mild compared to pre-pandemic years. Recently, Best-Selling Author and Medical Contributor Dr. Ian Smith teamed up with Mucinex on a nationwide satellite media tour to discuss the upcoming cold and flu season and some resources that can help. A video accompanying this announcement is available at: https://youtu.be/c4AY6pLO1kU Many health experts are predicting the 2022-2023 flu season will be a severe one, due to several factors. The main reason the flu basically disappeared the last two years was the behavior changes people made to avoid COVID – staying home, avoiding public gatherings, wearing masks, and not traveling. That also prevented the flu virus from spreading like usual. Those measures have been mostly abandoned – in addition, without the last two ‘flu seasons’ many individuals’ immunity to seasonal flu will be decreased. It is possible that we could see a higher rate of severe illness due to the flu this year. Many experts have looked to Australia, where flu season runs from April to September. They are just coming out their most devastating flu season in five years, which could be a precursor as to what we can expect to see in the U.S. The best way to prevent and limit the effects if you do contact the flu is to get vaccinated. It can take up to two weeks for the vaccine to be most effective after administration, and since the influenza virus is already circulating, it is best to do this as soon as possible. Key preventative measures like washing your hands often and covering your nose and mouth with a tissue when you cough or sneeze and sneezing into your elbow if you don’t have a tissue can be extremely effective in preventing the spread of germs. If you do find yourself with flu-like symptoms, such as cough and congestion, there are options available to help you feel better and over-the-counter remedies are the first stop. While over-the-counter remedies don’t cure the flu virus, they can go a long way towards helping treat the symptoms. Dr. Ian’s go-to is Mucinex Extended-Release Tablets, because they are clinically proven to last up to 12 hours. As the #1 pharmacist recommended expectorant, Mucinex Extended-Release Tablets relieve chest congestion and thin and loosen mucus, which can provide relief for your chest congestion, making your cough more productive. People must use over-the-counter products as directed. If symptoms persist, you should contact your healthcare professional and get checked out if deemed necessary. You can find Mucinex online at Mucinex.com or stop by Walmart or your local pharmacy retailer. About Dr Ian Smith Dr. Ian Smith is the author of the #1 New York Times bestselling books, SHRED: THE REVOLUTIONARY DIET, and SUPER SHRED: The Big Results Diet, and BLAST THE SUGAR OUT. Dr. Smith’s highly anticipated newest book, The Clean 20, became an instant New York Times best seller, helping hundreds of thousands of people reduce bad sugars from their diet, lose weight, lower blood sugar levels, and cut the cravings. Dr. Smith was appointed by President Obama to a second term on the prestigious President’s Council on Fitness, Sports, and Nutrition. He is currently the medical contributor and co-host of the nationally syndicated television show The Rachael Ray Show. He is a former co-host of the Emmy award winning syndicated daytime talk show, The Doctors. He also served as the medical/diet expert for six seasons on VH1’s highly-rated Celebrity Fit Club, and is the creator and founder of the national health initiatives The 50 Million Pound Challenge and The Makeover Mile. Dr. Smith is the former medical correspondent for NBC News network and for NewsChannel 4 in New York, where he filed reports for NBC Nightly News and The Today Show as well as WNBC’s various news broadcasts. He has appeared extensively on various broadcasts including The Oprah Winfrey Show, The View, Dr. Oz, Steve Harvey Show, The Talk, Larry King Live, Anderson Cooper 360, CNN, MSNBC and many more. He has written for various publications including Time, Newsweek, Men’s Fitness, and the New York Daily News, and has been featured in several other publications including, People, Redbook, Details Magazine, Essence, Ebony, University of Chicago Medicine on the Midway, Cosmopolitan, and Black Enterprise. Contact Details YourUpdateTV +1 212-736-2727 yourupdatetv@gmail.com

November 04, 2022 10:05 AM Eastern Daylight Time

Video

Willamette Valley Benefits Joins AmeriLife

AmeriLife

AmeriLife Group, LLC (“AmeriLife”), a national leader in developing, marketing, and distributing life and health insurance, annuities and retirement planning solutions, announced today that it has partnered with Willamette Valley Benefits. Under the leadership of longtime industry veteran and CEO Elma Friend, Willamette Valley Benefits specializes in the marketing and distribution of Medicare Advantage, Medicare Supplement, and ancillary health solutions to clients throughout the Pacific Northwest and Mountain West. Per the agreement, terms of the deal were not disclosed. "This is an exciting time for women in this industry,” said Friend. “We are a women-owned and operated business and have continued to see growth. I believe in the nurturing, compassionate side of what we do and taking care of people is our priority. As a female-driven operation, we continue to see more women entering this field and it’s a great fit because AmeriLife understands that diverse, empowered and client-first agents are key to delivering the right solutions and service.” Headquartered in Portland, OR., Willamette Valley Benefits has, for more than 16 years, helped clients navigate the complexities of healthcare via a dedicated staff of Medicare and health insurance professionals. Friend, also its founder, started with HealthNet and in launching Willamette Valley Benefits, committed herself and her firm to being a service-oriented business. Today, Willamette Valley Benefits takes a supportive approach when it comes to bringing in new agents. They collaborate with them consistently on education, service, compliance and support, ensuring that each agent has what they need to build their book of business and have a better work-life balance. Willamette Valley Benefits’ growing team currently serves communities in Oregon, Washington, Arizona and Idaho, and has recently branched into Texas. Already deeply familiar with AmeriLife through its longstanding relationship with Jack Schroeder and Associates, Willamette Valley Benefits will now have full access to AmeriLife’s best-in-class technology and resources and leading distribution platform, positioning the firm for significant growth. “Willamette Valley Benefits is, without a doubt, representative of the new face of our industry,” said Mike Vietri, AmeriLife’s Chief Distribution Officer. “AmeriLife is excited to add such a diverse and performative agency to its portfolio of companies. We look forward to working with Elma and her team to grow their operations and empower more of their agents to help people live longer, healthier lives.” ### About Willamette Valley Benefits Willamette Valley Benefits, Inc. is a local independent Medicare and health insurance agency based in Milwaukie, OR. With a passion for helping clients navigate their insurance needs, they are committed to making sure the information clients receive is clear and understandable. The team collaborates directly with clients to reduce their workload, clear up confusion and be confident that there is someplace to go when their health coverage questions need to be answered. Willamette Valley Benefits has been in business for more than 16 years and has grown through word of mouth, offering its services at no cost to those who need assistance. For more information visit WVBenefits.com. About AmeriLife AmeriLife’s strength is its mission: to provide insurance and retirement solutions to help people live longer, healthier lives. In doing so, AmeriLife has become recognized as the leader in developing, marketing, and distributing life and health insurance, annuities, and retirement planning solutions to enhance the lives of pre-retirees and retirees across the United States. For more than 50 years, AmeriLife has partnered with top insurance carriers to provide value and quality to customers served through a distribution network of over 300,000 insurance agents and advisors and more than 100 marketing organizations and insurance agency locations nationwide. For more information, visit AmeriLife.com, and follow AmeriLife on Facebook and LinkedIn. Contact Details Media Jeff Maldonado +1 321-297-1112 jmaldonado@amerilife.com Partnership Inquiries Patrick Nichols +1 727-726-0726 pnichols@amerilife.com Company Website https://amerilife.com/

November 03, 2022 01:00 PM Eastern Daylight Time

Software Effective Solutions’ (OTC: SFWJ) Medcana Acquires Controlling Stake in Eko2o Environmental

Software Effective Solutions Corp.

McapMediaWire -- Software Effective Solutions Corporation (OTC: SFWJ) (“The Company”, “SFWJ”) subsidiary Medcana has acquired a controlling stake in Eko2o Environmental Solutions S.A.S. of Medellin, Antioquia. a company focused on developing infrastructure for agriculture, primarily with greenhouse construction and irrigation systems in Colombia and South America. With this acquisition, the Company is expanding its infrastructure and overall capabilities toward additional market opportunities and strategic partnerships. Juan Ricardo Velez is CEO for Eko2o and is renown in the industry for his experience and track record for success. As well, execs are confident that the engineering talent and vendor support that comes with this acquisition will set Eko20 as a market leader in Colombia and South America very quickly. Gabriel Diáz, CEO of Medcana states “This acquisition further amplifies our investments in the industry and provides expansive opportunities for growth in the industry. We are honored to be working with a team equipped with a deep understanding of, and extensive experience in greenhouse and irrigation technologies. We are building something special here and Eko2o is a very important piece of our puzzle.” Juan Ricardo Velez CEO and founder of Eco2o is a Civil Engineer from University of Medellin, served and retired as army Major in Colombian Army. He has advanced studies in Israel and Spain focusing on irrigation systems and greenhouses. His experience and his team are unrivaled in Colombia and most of South America. About Software Effective Solutions/MedCana: Software Effective Solutions/MedCana is a global infrastructure and holding company in the cannabis industry. The recent acquisition of a software company expanded the offering to provide traceability from plant to product. MedCana's initial focus is on developing clients and companies in Latin America, with an initial focus on Colombia and partnerships with laboratories, research facilities, and hospitals throughout the world. SAFE HARBOR STATEMENT This press release contains forward-looking statements that can be identified by terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Many forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results implied by such statements. These factors include, but are not limited to, our ability to continue to enhance our products and systems to address industry changes, our ability to expand our customer base and retain existing customers, our ability to effectively compete in our market segment, the lack of public information on our company, our ability to raise sufficient capital to fund our business, operations, our ability to continue as a going concern, and a limited public market for our common stock, among other risks. Many factors are difficult to predict accurately and are generally beyond the company's control. Forward-looking statements speak only as to the date they are made, and we do not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made. Signed. /s/ Jose Gabriel Diaz, CEO www.medcana.net info@medcana.co FOR MORE INFORMATION PLEASE CONTACT: Chris Greta 512-587-5175 chris@chrisgreta.com www.medcana.net info@medcana.co Contact Details Chris Greta +1 512-587-5175 chris@chrisgreta.com Company Website https://www.medcana.net/

November 03, 2022 10:57 AM Eastern Daylight Time

SHIFTKEY AWARDED TOP HONOR AT ANNUAL DALLAS 100 AWARDS

ShiftKey

ShiftKey, a leading technology platform bringing critical workforce solutions, was named the No. 1 fastest-growing privately held company in Dallas at the annual Dallas 100 Awards Gala, presented by Southern Methodist University’s Cox School of Business. The Dallas 100 recognizes the fastest-growing small, independent, privately held companies in North Texas based on three years of continuous revenue growth. To qualify for the Dallas 100, organizations must be headquartered in the Dallas-Fort Worth area and have revenue earnings of between $500,000 to $100 million dollars. “ShiftKey was born out of a vision to transform the workforce, creating opportunities for healthcare professionals to pursue independent, flexible opportunities while addressing serious workforce gaps to keep up with increased patient demand,” said Tom Ellis, CEO, ShiftKey. “We’re proud of our Dallas roots, so this honor means a lot to our team as we continue to position Dallas as a leading technology hub that brings real solutions to our workforce, healthcare systems and economy.” ShiftKey was founded in 2016 in Dallas by technology entrepreneur and innovator Tom Ellis. The company has experienced rapid growth, starting with 25 employees in 2016 and growing to 200 employees today. Since ShiftKey launched, more than 50 million hours in open shifts have been posted to its marketplace platform. The company has a network of 200,000 independent healthcare providers and partners with more than 3,000 healthcare facilities across 30+ states. Today, ShiftKey is the largest technology platform for connecting independent licensed healthcare professionals with open shifts at healthcare facilities across the United States. The company takes a marketplace approach, empowering the provider to determine when, where and how much they want to work, while giving healthcare facilities access to a vast network of professionals with diverse expertise and specializations to meet unique staffing needs in the moment. To learn more about ShiftKey’s exciting growth journey and opportunities for facilities and independent providers, follow ShiftKey on LinkedIn at https://www.linkedin.com/company/myshiftkey/. About ShiftKey Founded in 2016, Dallas-based ShiftKey is the largest technology platform for connecting independent licensed healthcare professionals with open shifts at healthcare facilities across the United States. Leveraging marketplace dynamics and deep industry knowledge, the company is playing a vital role in mitigating America’s healthcare staffing shortages, empowering providers to choose when, where and how much to work, while facilitating direct connections with healthcare facilities. Since its inception, healthcare facilities have posted more than 50 million hours of shifts on ShiftKey, gaining access to a vast talent network of licensed independent healthcare professionals with diverse expertise and specializations to meet their unique staffing needs in the moment. For more information, visit www.ShiftKey.com. Contact Details Curley Company for ShiftKey Lorianne Walker +1 410-688-1330 lorianne@curleycompany.com Company Website https://www.shiftkey.com/

November 03, 2022 10:32 AM Eastern Daylight Time

THE INDO-AMERICAN ARTS COUNCIL ANNOUNCES ANNUAL WEEKLONG LITERARY FESTIVAL

IAAC

- In Its 8th Year, the IAAC Literary Festival offers an intimate interaction with the leading minds and works of authors and poets writing about the Indian experience - The Indo-American Arts Council ( IAAC ), the organization dedicated to celebrating and showcasing the arts in North America, announced today the lineup for its eighth annual Literary Festival on November 7-13, 2022, in New York. Notable speakers, making in-person appearances at the Caelum Gallery (526 W 26th St.) in NY’s renowned Chelsea neighborhood, include Padma Shri, Barkha Dutt, Priya Kumari and Raza Mir. In continuation of its honored tradition, IAAC will also host a live Poetry Panel headlining Arundhathi Subramaniam and moderated by poetry curator, Dr. Ravi Shankar. Prior to the in-person weekend events, there will be a series of virtual events hosted on Facebook and YouTube each evening starting November 7-11 at 6:30 p.m. ET, which will feature ten writers including Nobel Peace Prize winner Kailash Satyarthi; London-based restaurateur and Netflix’s “Chef’s Table” star, Asma Khan with Michelin Chef Vikas Khanna - author of the world’s first “phygital” (physical and digital) cookbook; plus, actress, dancer and choreographer, Rukmini Vijayakumar. This series also includes a dedicated Children’s Literary Panel on Tuesday, November 8, 2022 which will showcase readings of “When Blackbirds Fly” by Hannah Lalhlanpuii and “Jamlo Walks” by Samina Mishra. "IAAC's Literary Festival showcases writers who bring stories of the Indian experience and ethos to the world. Even as they set new standards of literary excellence, they excite our imagination and shape humanity's future through their thought leadership. The festival attendees will become part of extraordinary conversations. Supporting the festival will be a stellar group of moderators who themselves are literary luminaries. As always there will be a focus on first time regional translations, children's literature and poetry," said Rakesh Kaul, Vice Chairman, IAAC. IAAC’s literary festival will be an intense two-day immersive experience featuring thought-provoking conversations, readings and discussions of stories told by courageous authors. Each authors' skill and expertise cover a wide range of civilizational and cultural topics including archeology, design, dance, history, compassion, wonder and the culinary arts. A panel of four poets will showcase powerful word-play that will make imaginations soar and speak directly to hearts, young and old. Refreshments, breakfast and lunch will be served, wine and cheese will accompany the poetry session. The festival wraps on a high note with the Annual Gala on November 13th. “At IAAC, we pride ourselves on our ability to seek out and find foundational storytellers who are not only noteworthy for their skill with language but whose seminal works also weave remarkable narratives that shape the world around them. This year is no exception; I have had the privilege to work with a dedicated team of literature lovers whose hard work and energy made this festival possible,” said Preethi Urs, Literary Festival Director, IAAC. A full list of writers and featured works below. For the full schedule with dates, times and moderators, please visit IAAC.us. Virtual Events (November 7-11): Kailash Satyarthi's greater body of work Ammu: Indian Home Cooking to Nourish your Soul (Interlink Books, May 2022) by Asma Khan Sacred Foods of India in NFT format (Akshaya, June 2022) by Vikas Khanna His Holiness the Dalai Lama in 100 Anecdotes (India Penguin, December 2022) by Arthy Muthanna Singh and Mamta Nainy The Dalai Lama: Leadership and the Power of Compassion (Interlink Books, November 2022) by Ginger Chih which includes a forward by His Holiness the Fourteenth Dalai Lama Finding Shiva: An Inner Journey of the Performative Experience (INDIC, 2021) by Rukmini Vijayakumar Virtual Children’s Panel: When Blackbirds Fly (Duckbill, February 2022) by Hannah Lalhlanpuii Jamlo Walks (India Puffin, September 2021) by Samina Mishra Somnath Hore: Wounds (Art1st, August 2021) conceptualized by Ritu Khoda, written by Likla Lall and featuring illustrator, Kripa (additionally, featuring in-person on November 13) In-Person Events (November 12-13): The Way of the Goddess: Daily Rituals to Awaken Your Inner Warrior and Discover Your True Self (TarcherPerigee, September 2022) by Ananta Ripa Ajmera Tata's Leadership Experiment: The Story of the Tata Administrative Service (HarperBusiness, August 2022) by Bharat Wakhlu, Mukund Rajan, Sonu Bhasin TO HELL AND BACK: Humans of COVID (Juggernaut, February 2022) by Barkha Dutt The Greatest Telugu Stories Ever Told (Rupa, March 2022) translated by Tamraparni Dasu and Dasu Krishnamoorty A Country Called Childhood: A Memoir (Aleph Book Company, July 2022) by Deepti Naval [Block] Chain Reaction - The Future of How We Live and Work (Soul Excellence Publishing, January 2022) by Elizebeth Varghese Tomb of Sand: A Novel by Geetanjali Shree (Tilted Axis Press, August 2021), translated by Daisy Rockwell Shehnai Virtuoso and Other Stories by Dhumketu (Deep Vellum Publishing, July 2022) translated by Jenny Bhatt Rajaraja Chola: King of Kings (Aleph Book Company, November 2022) by Kamini Dandapani Dava Shastri's Last Day (Grand Central Publishing, November 2021) by Kirthana Ramisetti A Matter of Trust (HarperCollins India, July 2021) by Meenakshi Ahamed The View from the Very Best House in Town (Walker Books US, February 2022) by Meera Trehan The Soul Catcher (Bodes Well Publishing, September 2021) by Monica Bhide Mirror Made of Rain (The Unnamed Press, May 2022) by Naheed Phiroze Patel The Candid Life of Meena Dave (Lake Union Publishing, June 2022) by Namrata Patel People of the Indus (India Penguin, November 2022) by Nikhil Gulati Leaf Talks Peace - Buddha's Message of Harmony (Eternal Tree Books, May 2022) by Priya Kumari Talent: The Market Cap Multiplier (Ideapress Publishing, January 2022) by Ram Charan and Anish Batlaw Murder at the Mushaira: A Novel (Rupa Publications India, January 2021) by Raza Mir Smashing the Patriarchy: A Guide for the 21st-Century Indian Woman (Rupa, November, 2021) by Sindhu Rajasekaran KALA - Essays on Contemporary Design Aesthetics (Times Group Books, 2020) edited by Padma Shri Sunita Kohli Somnath Hore: Wounds (Art1st, August 2021) conceptualized by Ritu Khoda, written by Likla Lall and featuring illustrator, Kripa Notable International Poets: Love Without a Story (Westland, April 2019) by Arundhathi Subramaniam My Body Lives Like a Threat (Flowersong Press, January 2022) by Megha Sood Time Regime (Gaudy Boy, March 2022) by Jhani Randhawa Singing in the Dark (Vintage Books, October 2020) edited by Nishi Chawla and K Satchidanandan Attendance Details: For a complete calendar of events between on November 7-13, 2022, visit https://iaac.us/iaac-literary-festival-2022/ RSVP for both in-person and online events at: https://www.eventbrite.com/e/iaac-literary-festival-2022-tickets-446199724387 Social Media for IAAC: Facebook: https://www.facebook.com/iaac.us YouTube: https://www.youtube.com/channel/UC7XldGWApKYy-IvQPapxFJg Twitter: https://twitter.com/IAArtsCouncil Instagram: https://www.instagram.com/iaacny Hashtag: #IAACLitFest For a full press kit including photos and posters: https://drive.google.com/drive/folders/1DtbCXBSbA25yTQmf7vfMEWcdWFOGszA-?usp=sharing For IAAC Suman Gollamudi, Executive Director, Indo-American Arts Council suman.gn@iaac.us About Indo-American Arts Council (IAAC): The IAAC supports all the artistic disciplines in classical, fusion, folk and innovative forms influenced by the arts of India. We work cooperatively with colleagues around the U.S. to broaden our collective audiences and to create a network for shared information, resources and funding. Our focus is to help artists and art organizations in North America as well as to facilitate artists from India to exhibit, perform and produce their work here. The IAAC is a 501(c)(3) tax-exempt organization. All donations are tax-deductible to the fullest extent allowable by law. For information, please visit www.iaac.us. For a full press kit including photos and posters: https://drive.google.com/drive/folders/1DtbCXBSbA25yTQmf7vfMEWcdWFOGszA-?usp=sharing Contact Details Indo-American Arts Council Suman Gollamudi, Executive Director suman.gn@iaac.us

November 02, 2022 04:57 PM Eastern Daylight Time

Image

Intus Care Closes $14.1M Series A to Advance Adoption of First-of-its-kind Predictive Analytics Platform for Geriatric Populations

Intus Care

Intus Care, developer of an innovative predictive analytics platform aimed at improving geriatric care outcomes, today announced the close of its Series A, securing over $14M led by Deerfield Management. Other undisclosed investors contributed to the raise through additional cash investments and conversion of existing debt. Founded in 2019 by Brown University undergraduate students, Intus Care’s mission is to empower geriatric care providers through data to deliver more effective patient management and treatment for dual-eligible seniors -- some of the most socially vulnerable and clinically complex people in the U.S. “We are extremely impressed both by the impact that Intus Care’s technology is poised to have on patient outcomes, and by the passion and dedication of its team,” said Dr. Julian Harris, operating partner at Deerfield Management. “We are proud to invest in a company we believe will be vital to revolutionizing geriatric care.” Intus Care’s technology platform enables care providers to mitigate preventable high-utilization events, track quality interventions, and equip healthcare management teams with vital actionable insights to make informed decisions for senior patients to improve their health outcomes. Its digital healthcare platform integrates with electronic health records, claims, and accounting software to highlight clinical risks in patients and display organizational data. This offers a holistic view of each patient in an organization, allowing healthcare teams to better plan, manage, and provide quality care to the most vulnerable senior populations in our communities. “To have an investor as esteemed in the healthcare industry as Deerfield Management recognize our value enough to lead our Series A is truly humbling,” said Robbie Felton, CEO and co-founder of Intus Care. “As a child, I watched my mother – then a geriatric social worker in Detroit – navigate the obstacles of caring for a disadvantaged population. Today, it makes me extremely proud to be providing caregivers with predictive analytics technology that will allow them to make more informed decisions for their patients that may lead to better outcomes.” Intus Care currently works with over 25 PACE Programs in 13 states who are utilizing its first-of-its-kind predictive analytics platform and entered a Letter of Understanding with the National PACE Association to pursue a strategic partnership. “Robbie and I are proud to be impacting the elder care space, and also hope to inspire other young entrepreneurs of color,” said Evan Jackson, COO and co-founder of Intus Care. “We are very appreciative to have earned the support of Deerfield Management and our other investors and are excited by the possibilities that their investment will enable us to actualize.” The latest investment round will position the company to maximize greater technological opportunities through data, honing product strategy that will support a major scale-up of their current service offerings. They also plan to grow their human capital by attracting, hiring, and retaining strong talent committed to their mission. About Intus Care Intus Care synthesizes data to improve care and reduce hospitalizations for some of the most socially vulnerable and clinically complex patients in today’s healthcare system – senior citizens. The company has created a unique data-driven predictive analytics platform designed for organizations such as PACE programs, nursing homes, long-term care facilities, and home care agencies. It easily integrates with existing electronic health records, claims, and financial software to automatically extract and analyze data. By highlighting participant risk and care-focused information, the Intus Care software empowers clinicians, nurses, and other care providers by informing decisions that improve outcomes and reduce unnecessary costs. Learn more at intuscare.com. Contact Details SVM Public Relations Jordan Bouclin +1 401-490-9700 intuscare@svmpr.com Company Website https://www.intuscare.com/

November 02, 2022 10:40 AM Eastern Daylight Time

News Release

Livewire’s Estrella Weedery Is The World’s First Estate-Grown Weedery — A Sustainable Cannabis Farm and Destination Focused On Premium Organic-Style Specialty Cannabis Products

LiveWire Ergogenics, Inc.

Livewire Ergogenics Inc. trading at the OTC Marketplace under (OTCMKTS: LVVV) is a company focused on acquiring, managing, leasing, and licensing special-purpose real estate properties and operations conducive to producing high-quality, handcrafted, and organically grown specialty cannabis products for medical and recreational adult-use in California. The company’s main operations are in Paso Robles, California, including the recently acquired Estrella Ranch nestled among hundreds of world-renowned vineyards and Makana Ola Farms In Humboldt, California. The company says the Estrella Ranch property is the home to the world’s first “Estate Grown Weedery”, following the well-established vineyard business model, eventually developing it into a cannabis tourist destination in California. Already an active cannabis-producing property, the company is turning Estrella Ranch into multiple revenue-stream properties while preserving its natural splendor and prioritizing environmentally conscious cultivation and business practices every step of the way, leaving behind the smallest possible carbon footprint possible. Handcrafted Organic Cannabis Specialty Products May Help Keep Profit Margins High With its initial pilot harvest completed last October, Livewire took the first step toward establishing the Estrella Weedery brand. The harvest was carried out by Livewire’s affiliate company, Estrella River Farms which operates the cultivation on the Estrella property. ERF is using state-of-the-art techniques to develop a sustainable, organic farm for growing a variety of premium cannabis specialty products. The tractorless cultivation process uses less water, less fertilizer, and no toxic pesticides. The result is high-potency, premium cannabis that takes considerably less water than comparable cultivation processes to produce. To stay competitive with bigger California producers like Lowell Farms Inc. (OTCQX: LOWLF) or Glass House Brands (OTCQX: GLASF), LiveWire’s Estrella River Farms is focused on cultivating organic-style specialty products with higher profit margins. By focusing on quality instead of quantity (grow by the pound - sell by the gram), the company hopes to avoid the high cost and low return of mass-produced cannabis. As the trend toward widespread legalization continues with 52% of Americans living in areas with marijuana legalized in some form, the cost of cannabis has dropped in the United States, sinking to its lowest price in over three years in June. In Canada, nationwide legalization was followed by a 13% drop in price in the first year. Since then, retail prices across categories have continued to dip as more producers entered the space still having to compete with larger illicit sales for market share. While that drop will likely level out, companies with tight margins are going to have a hard time staying competitive without differentiating their products in distinctive ways. For Livewire, that differentiation comes from quality specialty products, environmentally conscious production, and operating with significantly lower production costs to keep profit margins high. In addition to its business-to-business sales, the company intends to get its premium Estrella Weedery branded product onto every dispensary shelf in California — either as a specialty product under its own brand or as a licensed private-label product under third-party brands. Livewire has also partnered with home-delivery services Kushagram and Green Eagle to deliver its cannabis products directly to consumers. Applying The Tried And True Vineyard Model To Cannabis Cultivation Is Expected Generate Additional Revenue The ultimate vision at Estrella Ranch is simple: Sell its high-quality specialty products B to B and Direct to Consumers. Ultimately, create an idyllic wellness retreat complete with scenic vistas and currently over 130,000 square feet of sustainably cultivated cannabis, multiple offices, secure storage buildings, and large living quarters. When the project is finished, Livewire hopes to have roughly six (6) acres of outdoor growing area, and 22,000 square feet of indoor cultivation,— all while carefully preserving the natural, open landscape of rolling hills and well-watered ranchland. Livewire’s Plan Is to Generate Multiple Revenue Streams From One Low-Cost Operation Livewire chose the Estrella Ranch location, in part, for the ideal micro-climate that makes organic, sun-grown outdoor cannabis cultivation possible. In less ideal climates, cultivators typically opt for indoor production to increase yield and compensate for poor weather or lack of sun. But growing indoors means spending more on energy, facility maintenance, and other expenses that bring median average production costs up to $472 per pound. At Estrella, Livewire says production costs average under $100 per pound for its organic-style outdoor cultivation. The company states that the lower production cost paired with its plan to eventually generate revenue from the property via a first-of-its-kind cannabis wellness retreat and both direct-to-consumer and business-to-business sales of the cannabis it grows creates the potential for a wide margin and substantial growth potential. Livewire Ergogenics Inc. focuses on acquiring, managing, and licensing well-qualified cannabis real estate locations to establish fully compliant and permitted facilities to produce cannabis-based products and establish relationships for the statewide distribution of these products in California. This includes developing and licensing high-quality organic cannabinoid-based products and services and creating the high-quality "Estrella Grown Weedery™" brand via its subsidiary/affiliate companies Estrella Ranch Partners, Estrella River Farms, Makana Ola, and CaliCruz Farms. LiveWire Ergogenics does not produce, sell, or distribute products that violate the United States Controlled Substances Act. This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Tristan Cavato ir@livewireergogenics.com

November 02, 2022 08:15 AM Eastern Daylight Time

Valant Unveils MYIO, a First-of-its-Kind Patient Portal Mobile App for Behavioral Healthcare

Valant

Valant, a leading EHR for behavioral healthcare practices, today launched MYIO, the first all-in-one behavioral health-specific patient engagement mobile app. MYIO, which is short for My Improved Outcomes, offers a secure solution intended to improve both patient and practice outcomes. It enables practices to boost productivity and streamline operations while increasing patient engagement. With MYIO, patients can join telehealth sessions, sign intake forms, complete assessments, securely message their behavioral health provider, view and request appointments, update payment information, and make online payments. This alleviates the burden often placed on administrative staff and allows them to handle patient questions and requests that do not require their provider's attention. Additionally, MYIO alleviates manual tasks once left to providers, giving them the opportunity to focus on patient care. MYIO helps behavioral healthcare practices bypass the manual entry of patient data into multiple systems, thereby improving operational efficiencies. With the app, new patients can easily onboard by entering demographic data and submitting credit card and insurance information, signing clinical intake forms, requesting appointments, paying balances, and more. “Mental health requires constant communication and engagement to keep patients motivated to continue their care. Our vision with MYIO is to give providers a means to keep that engagement going, long after appointments are complete,” said Valant’s Chief Executive Officer, Ram Krishnan. “We are pleased to offer patients a cohesive, supportive experience and providers the technology to help make high-quality behavioral healthcare available to everyone while improving outcomes. Practices with outpatient behavioral health clients will benefit by having this secure central hub to stay connected and also have access to health data.” While using the app, patients can communicate with their behavioral healthcare provider or office staff to schedule appointments, request prescription refills, and register for additional services from their portal account using the integrated secure messaging feature. Willamette Health & Wellness, a behavioral healthcare practice in Portland, OR, is an early adopter of the MYIO app. Prior to working with Valant, Williamette’s billing department spent hours manually sending patients billing statements and asking them to pay bills through a separate system. “Our previous billing process was very labor-intensive for the practice and unnecessarily complex for patients,” said Willamette Health & Wellness Billing Specialist Shea Musick. “We used to have an entire manual workflow dedicated to sending out statements, replying to questions, and directing patients to submit payments on the practice website via a third-party portal. Valant’s integrated patient portal app, MYIO, has completely streamlined the process, saving our office hours of administrative work each day.” MYIO offers integrated secure messaging and a streamlined way for behavioral healthcare practices to: Securely communicate with patients outside of appointments; Give patients access to their behavioral health information and upcoming appointments; Automatically collect and update patient information; Send outcome measures for patients to complete prior to and in between visits; Receive patient payments and signed intake or consent forms; Host virtual visits with patients, with the option to automatically collect payment prior to the session; and Offer behavioral health resources for ongoing patient education. The release of MYIO coincides with significant improvements to Valant’s browser-based patient portal experience and secure messaging feature. To learn more, visit valant.io. About Valant Valant is a cloud-based integrated EHR software suite that supports the administrative operations of behavioral healthcare practitioners, agencies, and clinicians. The software offers features including individual and group appointment scheduling, treatment planning, medication management, patient engagement, billing, and reporting. Valant collects and organizes data from patients and providers, documents them using guided protocols, and stores them securely. Actionable insights and reports are also generated based on the data collected. Valant is built for large outpatient practices and solo providers including psychiatrists, nurse practitioners, psychologists, therapists, and counselors. To date, thousands of organizations across all 50 states utilize Valant to decrease costs and manage ever-changing compliance requirements. Learn more at valant.io. Contact Details Jennifer Mirabile Trust Relations valant@trustrelations.agency

November 02, 2022 08:00 AM Eastern Daylight Time

Video

PROTEXT MOBILITY, INC. (TXTM) AND RSAMMDA LLC (DELAWARE) PROVIDES SHAREHOLDER UPDATE

ProText Mobility, Inc.

Protext Mobility, Inc. (OTC PINK: TXTM) and RSAMMDA LLC (Delaware) (“RSAMMDA.LLC”) are pleased to provide the following shareholder update and announce an initial order for 2.33 million pounds of Genus Cannabis Sativa under a supply agreement. Dr. Ahmed Jamaloodeen (Dr.J), Protext Chairman commented, “This is a terrific milestone and demonstrates years of hard work and relentless pursuit of educating the masses and government collaboration. The initial order calls for the delivery of 2.33 million pounds of cannabis, arguably the largest single cannabis flower and biomass order in history to date post legalization. The specific strain we are growing for this order is Charlottes Angel for high percentage CBD flower and biomass. Everything we do is under South Africa federally issued permits, and license to import, export, grow hemp and cannabis from seed to sale, R & D, as well as develop and distribute our own brand of finished products. “Our proprietary, branded CBD product line and online marketplace is anticipated to launch shortly. Due to our early pioneering of hemp and cannabis as a massive community uplift opportunity in South Africa, we were approved as the first government sponsored pilot project that would enable proof of concept to other farms as a blueprint of this business model. This early blueprint is now a proven business model for South African farmers, and we are now at the forefront of SA becoming a recognized global leader in hemp and cannabis production. To further these efforts, last week I attended the AFASA AGM conference and gave a presentation to 1000’s of farmers who are now part of the Cannabis Commodity Cluster Formation, which I’ve been appointed as National Cannabis Commodity Chairman – The first in history.” (link to Dr.J Cannabis Expo 2022 presentation discussing SA community uplift and cannabis: youtube.com/DR.J ) Dylon Du Plooy, Protext CEO, commented, “The hemp renaissance is well underway, with renewed interest from global industrial companies to find cheaper and greener resources that can be used to produce 1000’s of end product. America is decades behind the sustainable materials revolution. That represents a big opportunity for us to unlock the potential of industrial hemp in the world’s strongest economy, with the lowest cost product available globally. For South Africa, the opportunity is to take a global role in what we believe is the beginning of an industrial hemp renaissance. We can not only produce product at the lowest cost basis on a global basis, but we can monetize the farm with 3 annual grows, making our hemp, biomass, and cannabis much sought after from customers around the world. In fact, this substantial off take agreement for an initial 2.3 m illion pounds is being delivered to a US customer. Why? Not only for the quality of the product, but our cost basis is so competitive we can deliver product that includes freight shipping cost to US customers, that is lower than they can get anywhere in North America.” #TXTMTribe #TXTMTribeRaok #TXTMRaok. Dr. J continued, “As we have previously discussed, we believe there is significant value in the human capital derived from our knowledge, Government and other relationships, compliance, resources, facilities, biomass, and infrastructure that is invaluable. The Permits we are in possession of allow for Genus Cannabis Sativa import, export, grow & cultivation, research, testing, and end product development for global distribution, all of which are anticipated to be utilized by Protext with the end goal to commercialize the live plant extraction technology and bring superior end products to the global market. Having technology that’s been tested and proven to increased bioavailability by 10-15x is significant and puts us miles ahead of all competitors. Additional testing is anticipated to be conducted with cannabis being grown on the farm right now. The testing will focus on maximizing yield as well as testing various strains of Genus Cannabis Sativa. We will also begin conducting the R&D using the New Age Extraction Technology for other Indigenous Plant Flora with medicinal properties including Psilocybin. We believe that the significance of the implications our live plant Extraction Technology can have on not only our yield, but also on an entire industry with its 10-15X Bioavailability has been over looked due to the complexity of the science. In layman’s terms we stand to produce Natural Plant Based Medicine with 10-15 times more bioavailability than current products on the market, at a fraction of the cost. “As we previously discussed, but worth repeating, we entered into this transaction with Protext as we believe there to be numerous synergies by allowing access to certain assets of our established business’ with Protext as well as commercialize the Protext proprietary live plant extraction technology and processes into our existing Genus Cannabis Sativa infrastructure. Prior to the merger, Protext had collaborated with RSAMMD whereby the companies utilized Protext’s proprietary live plant extraction technology along with Kettle extraction equipment to conduct a series of live cannabis extraction testing at New Castle Farm under permits for Genus Cannabis Sativa, with the goal to produce an emulsion rich with cannabinoid but with little to no conversion of THC-A to psychoactive THC. We undertook a series of tests to prove out that the Kettle system and extraction technologies did what they were supposed to do. As part of our previous investigations, various tests were completed using live cannabis flower and leaf, rendered into liquid emulsions supplied by the farm in New Castle. Prior to now, it was hypothecated that processing live Genus Cannabis Sativa under lower temperatures would yield a rich nano-emulsion of phytocannabinoids while retaining the non-psychoactive precursor acid form (THC-A). Our investigations have conclusively demonstrated that full-spectrum cannabinoids can be extracted using the proprietary Kettle system, with minimal metabolic conversion, paving the way for advancement of medical research using non-psychoactive cannabis. What has also intrigued us are the findings from prior research and clinical trials that have shown that the Kettle system, when applied to other medicinal plants, can create an extract that is significantly more bioavailable (10-15x) than a standard extract. This means that our cannabis extract should be more potent while providing a dose that could potentially last up to 24 hours in the bloodstream, which is in-line with prior clinical results using other medicinal plants. Medically, this opens the door to a line of natural pharmaceuticals derived from cannabis but at a fraction of the price and with potentially superior outcomes. From a business perspective, an increase of bioavailability in that magnitude can be a game changer for cultivators as it essentially could increase the net yield by a factor of 10-15x per plant, per acre, per farm. This initial order is just the beginning and leadership is excited for what’s to come. We will lead the change we want to see in our world” concluded Dr.J. CONTACT INFORMATION For further information, or inquiries relating to partnerships in SA, JV opportunities and/or off-take/supply agreements please feel free to contact us Dylon Du Plooy at: dylon@rsammd.co.za Dr.J at: exportintl@aol.com Follow us at: https://twitter.com/RSAMMD https://twitter.com/ProtextP About Protext (OTC PINK: TXTM) Through its prior acquisitions, Protext has engaged in the research, testing and development of highly bioavailable botanical products all-natural ingredients formulated for nutraceutical and pharmaceutical applications through the use of proprietary live plant extraction technology. Website: www.protxtm.com About RSAMMDA.LLC: RSAMMDA.LLC. is a wholly owned subsidiary of TXTM focused on acquisitions with two principals, Mr. Dylon Du Plooy and Dr. Ahmed Jamaloodeen (“Dr. J”). Mr. Du Plooy is a South African pioneer in the research, cultivation, production and distribution of medical cannabis and cannabinoids. Dr. J operates the 5000 Hectare New Castle Farm as well as federally issued hemp permits issued by the Government of South Africa. Together, we partner with leading hospitals and universities globally to advance the clinical benefits and applications of cannabinoids. RSAMMDA.LLC founders are a group of medical doctors and pharmacists, and cannabis activists who have been at the forefront of medical cannabis legislation and South African cannabis legalization, which took place in September 2018. We are committed to the advancement of technology and scientific research that leads to an improved quality of life for patients around the world. Website: www.rsammda.com Safe Harbor Statement This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, we can give no assurance or guarantee that such expectations and assumptions will prove to have been correct. Forward- looking statements are generally identifiable by the use of words like "may," "will," "should," "could," "expect," "anticipate," "estimate," "believe," "intend," or "project" or the negative of these words or other variations on these words or comparable terminology. The reader is cautioned not to put undue reliance on these forward- looking statements, as these statements are subject to numerous factors and uncertainties, including but not limited to: adverse economic conditions, competition, adverse federal, state and local government regulation, international governmental regulation, inadequate capital, inability to carry out research, development and commercialization plans, loss or retirement of key executives and other specific risks. To the extent that statements in this press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made. The company disclaims any obligation to update information contained in any forward-looking statement. This press release shall not be deemed a general solicitation. Contact Details Dylon Du Plooy +27 72 889 2581 dylon@rsammd.co.za Company Website https://www.protxtm.com/

November 01, 2022 02:57 PM Eastern Daylight Time